Skip to main content

ORIGINAL RESEARCH article

Front. Immunol.
Sec. Inflammation
Volume 15 - 2024 | doi: 10.3389/fimmu.2024.1447523
This article is part of the Research Topic Morphological Changes in Immune Cells for Precision Sepsis Treatment View all articles

Assessing Sepsis-Induced Immunosuppression to Predict Positive Blood Cultures

Provisionally accepted
Enrique Hernández-Jiménez Enrique Hernández-Jiménez 1,2*Erika Paola Plata Menchaca Erika Paola Plata Menchaca 2,3Damaris Berbel Damaris Berbel 2Guillem López de Egea Guillem López de Egea 2Macarena Dastis-Arias Macarena Dastis-Arias 2Laura García-Tejada Laura García-Tejada 2Fabrizio Sbraga Fabrizio Sbraga 2Pierre Malchair Pierre Malchair 2Nadia García Muñoz Nadia García Muñoz 2Alejandra Larrad Blasco Alejandra Larrad Blasco 2Eva Molina Ramírez Eva Molina Ramírez 2Xose Pérez Fernández Xose Pérez Fernández 2Joan Sabater Riera Joan Sabater Riera 2*Arnau Ulsamer Arnau Ulsamer 2
  • 1 Loop Diagnostics S.L., Barcelona, Spain
  • 2 Institut d'Investigacio Biomedica de Bellvitge (IDIBELL), Barcelona, Spain
  • 3 Vall d'Hebron Research Institute (VHIR), Barcelona, Catalonia, Spain

The final, formatted version of the article will be published soon.

    Bacteremia is a life-threatening condition that can progress to sepsis and septic shock, leading to significant mortality in the emergency department (ED). The standard diagnostic method, blood culture, is time-consuming and prone to false positives and false negatives. Although not widely accepted, several clinical and artificial intelligence-based algorithms have been recently developed to predict bacteremia. However, these strategies require further identification of new variables to improve their diagnostic accuracy. This study proposes a novel strategy to predict positive blood cultures by assessing sepsis-induced immunosuppression status through endotoxin tolerance assessment. Optimal assay conditions have been explored and tested in sepsis-suspected patients meeting the Sepsis-3 criteria. Blood samples were collected at ED admission, and endotoxin (lipopolysaccharide, LPS) challenge was performed to evaluate the innate immune response through cytokine profiling. Clinical variables, immune cell population biomarkers, and cytokine levels (tumor necrosis factor [TNFα], IL-1β, IL-6, IL-8, and IL-10) were measured. Patients with positive blood cultures exhibited significantly lower TNFα production after LPS challenge than did those with negative blood cultures. The study also included a validation cohort to confirm that the response was consistent. The results of this study highlight the innate immune system immunosuppression state as a critical parameter for sepsis diagnosis. Notably, the present study identified a reduction in monocyte populations and specific cytokine profiles as potential predictive markers. This study showed that the LPS challenge can be used to effectively distinguish between patients with bloodstream infection leading to sepsis and those whose blood cultures are negative, providing a rapid and reliable diagnostic tool to predict positive blood cultures. The potential applicability of these findings could enhance clinical practice in terms of the accuracy and promptness of sepsis diagnosis in the ED, improving patient outcomes through timely and appropriate treatment.

    Keywords: Bacteremia, Sepsis, Endotoxin tolerance, Immunosuppression, Blood culture, TNFα, LPS, biomarkers

    Received: 11 Jun 2024; Accepted: 14 Oct 2024.

    Copyright: © 2024 Hernández-Jiménez, Plata Menchaca, Berbel, López de Egea, Dastis-Arias, García-Tejada, Sbraga, Malchair, García Muñoz, Larrad Blasco, Molina Ramírez, Pérez Fernández, Sabater Riera and Ulsamer. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Enrique Hernández-Jiménez, Loop Diagnostics S.L., Barcelona, Spain
    Joan Sabater Riera, Institut d'Investigacio Biomedica de Bellvitge (IDIBELL), Barcelona, Spain

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.